BeiGene's IPO

BeiGene raised a round of funding on February 03, 2016. Investors include Public.

BeiGene (百济神州) is a Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platfor…

Articles about BeiGene's IPO: